Home
Explore Technologies
Stanford OTL
The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.
Contact
|
Explore Technologies
Hybridomas 3B12, an Anti-Human Leucocyte Reagent, and Hybridoma 4H9, an Anti-Human T Cell Reagent
Stanford Reference:
82-068
Abstract
Hybridoma 4H9 can be used as an antileukocyte reagent capable of recognizing T-cell leukemia and distinguishing it from other forms of acute leukemia. Hybridoma 3B12 can also be used as an antileukocyte reagent distinquishing leukemia lymphoms from other forms of malignancy.
Publications
Blood Vol. 62, No 4
Innovators & Portfolio
Ronald Levy
more technologies from Ronald Levy »
Date Released
6/8/2009 12:00
Licensing Contact
Agreements Group
Request Info
79-066
Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368
82-008
A Monoclonal Antibody Specific For Mouse Granulocytes - RB6-8C5 and RA3-6B2
82-010
A Monoclonal Antibody Specific for the B-220 Surface Glycoprotein in Mouse (RA3-3A1)
more technologies »
Related Keywords
research tool
LS: research tool: antibody
leukemia
LS: research tool: cell line
